title: Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.
authors: Erica B
authors: EB
authors: Bernhardt
authors: Kelda H
authors: KH
authors: Walsh
authors: David J
authors: DJ
authors: Posey
authors: Christopher J
authors: CJ
authors: McDougle
mesh_terms: D000293:Adolescent; D020817:Asperger Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008559:Memantine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D018691:Excitatory Amino Acid Antagonists; D008559:Memantine